Proteomic profiling in liver cancer: another new page.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

1. Genetically predicted immune cells mediates the association between hepatocellular carcinoma and inflammatory proteins: a Mendelian randomization study.Discover oncology · 2025
   Article
2. The role of proteomics and radioproteomics in biomarkers of liver HCC for diagnosis, therapy and enhance interventional radiological treatments.Cancer reports and reviews · 2025
   Article
3. Pre-diagnostic plasma inflammatory proteins and risk of hepatocellular carcinoma in three population-based cohort studies from the United States and the United Kingdom.International journal of cancer · 2024
   Article
4. Comprehensive prognostic and immune analysis of sterol O-acyltransferase 1 in patients with hepatocellular carcinoma.World journal of hepatology · 2024
   Article
5. Hepatocellular Carcinoma Gene Expression:iLIVER · 2023
   Review
6. Impacts of the SOAT1 genetic variants and protein expression on HBV-related hepatocellular carcinoma.BMC cancer · 2021
   Observational
7. Genomic Landscape of HCC.Current hepatology reports · 2020
   Article
8. Annexin A2 promotion of hepatocellular carcinoma tumorigenesisWorld journal of gastroenterology · 2020
   Review
9. Assessment of liver cancer biomarkers.Gastroenterology and hepatology from bed to bench · 2020
   Review
10. Preoperative alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC): is this 50-year biomarker still up-to-date?Translational gastroenterology and hepatology · 2020
    Article

Corrections and comments

• Comment on
  Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma.2019

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.